Cases 1 - 10 of 11
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al
as 1:2023cv00334
Plaintiff:
Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. and others
Defendant:
Biocon Pharma Limited, Biocon Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Biocon Pharma Limited et al
as 1:2022cv00726
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Biocon Pharma Limited, Biocon Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. BIOCON PHARMA LIMITED et al
as 2:2021cv11261
Plaintiff:
CELGENE CORPORATION
Defendant:
BIOCON LIMITED, BIOCON PHARMA, INC. and BIOCON PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sanofi-Aventis U.S. LLC et al v. Biocon Limited
as 1:2017cv00003
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Biocon Limited
Cause Of Action: 35 U.S.C. § 271
Biocon Limited v. Abraxis Bioscience, Inc.
as 1:2016cv06894
Plaintiff:
Biocon Limited
Defendant:
Abraxis Bioscience, Inc.
Cause Of Action: 28 U.S.C. § 1332
ELI LILLY AND COMPANY v. BIOCON LIMITED
as 1:2016cv00469
Plaintiff:
ELI LILLY AND COMPANY
Defendant:
BIOCON LIMITED
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
